Literature DB >> 25432744

Affinity purification of in vitro transcribed RNA with homogeneous ends using a 3'-ARiBo tag.

Geneviève Di Tomasso1, Alix Salvail-Lacoste1, Jonathan Bouvette1, James G Omichinski1, Pascale Legault2.   

Abstract

Common approaches for purification of RNAs synthesized in vitro by the T7 RNA polymerase often denature the RNA and produce RNAs with chemically heterogeneous 5'- and 3'-ends. Thus, native affinity purification strategies that incorporate 5' and 3' trimming technologies provide a solution to two main disadvantages that arise from standard approaches for RNA purification. This chapter describes procedures for nondenaturing affinity purification of in vitro transcribed RNA using a 3'-ARiBo tag, which yield RNAs with a homogeneous 3'-end. The applicability of the method to RNAs of different sequences, secondary structures, and sizes (29-614 nucleotides) is described, including suggestions for troubleshooting common problems. In addition, this chapter presents three complementary approaches to producing 5'-homogeneity of the affinity-purified RNA: (1) selection of the starting sequence; (2) Cse3 endoribonuclease cleavage of a 5'-CRISPR tag; or (3) self-cleavage of a 5'-hammerhead ribozyme tag. The additional steps to express and purify the Cse3 endonuclease are detailed. In light of recent results, the advantages and limitations of current approaches to achieve 5'-homogeneity of affinity-purified RNA are discussed, such that one can select a suitable strategy to purify the RNA of interest.

Keywords:  ARiBo tag; Affinity purification of RNA; CRISPR; CRISPR-specific nuclease; Hammerhead ribozyme; Lambda N protein; Lambda boxB RNA; Riboswitch; T7 RNA polymerase; glmS ribozyme

Mesh:

Substances:

Year:  2014        PMID: 25432744     DOI: 10.1016/B978-0-12-801122-5.00003-9

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  2 in total

1.  Rapid NMR screening of RNA secondary structure and binding.

Authors:  Christina Helmling; Sara Keyhani; Florian Sochor; Boris Fürtig; Martin Hengesbach; Harald Schwalbe
Journal:  J Biomol NMR       Date:  2015-07-19       Impact factor: 2.835

2.  ARiBo pull-down for riboproteomic studies based on label-free quantitative mass spectrometry.

Authors:  Geneviève Di Tomasso; Lisa M Miller Jenkins; Pascale Legault
Journal:  RNA       Date:  2016-09-22       Impact factor: 4.942

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.